Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-05-11 @ 2:21 PM
Study NCT ID:
NCT06643793
Status:
RECRUITING
Last Update Posted:
2025-01-28
First Post:
2024-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC
Sponsor:
Affiliated Hospital of Nantong University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CRC-IIT-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None